Hodgkin lymphoma in patient with primary immunodeficiency: clinical features and treatment approaches
Primary immunodeficiencies (PID) are genetically determined irreversible disorders of structure and/or functions of the immune system's cellular and humoral components, accompanied by frequent infectious diseases and contributing to the development of malignant neoplasms. Lymphomas are the most...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2022-07-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/560 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839574396746858496 |
|---|---|
| author | K. I. Utesheva E. S. Belyaeva T. T. Valiev A. A. Odzharova |
| author_facet | K. I. Utesheva E. S. Belyaeva T. T. Valiev A. A. Odzharova |
| author_sort | K. I. Utesheva |
| collection | DOAJ |
| description | Primary immunodeficiencies (PID) are genetically determined irreversible disorders of structure and/or functions of the immune system's cellular and humoral components, accompanied by frequent infectious diseases and contributing to the development of malignant neoplasms. Lymphomas are the most frequent oncological disease in PID patients: non-Hodgkin's lymphomas occur in 60 % of malignant neoplasms cases, Hodgkin lymphoma - in 20 %, leukemias - in 10 %, solid tumors - in 10 %. The risk of malignant lymphoproliferative diseases in PID patients amounts to 4-25 %, with the overall incidence of cancer 100-200 times higher than in immunocompetent population. Results of malignant neoplasms treatment in children with PID remain unsatisfactory due to the high rate of relapsed, refractory disease and anticancer therapy complications.This paper presents a clinical case of Hodgkin lymphoma with atypical localization in a female PID patient. peculiarities of this case are eye socket soft tissue involvement, slow response to therapy, and a high rate of infectious complications. |
| format | Article |
| id | doaj-art-0c138a72cbe147d3a0f7a6f61a01d9f0 |
| institution | Matheson Library |
| issn | 1818-8346 2413-4023 |
| language | Russian |
| publishDate | 2022-07-01 |
| publisher | ABV-press |
| record_format | Article |
| series | Онкогематология |
| spelling | doaj-art-0c138a72cbe147d3a0f7a6f61a01d9f02025-08-04T13:57:51ZrusABV-pressОнкогематология1818-83462413-40232022-07-01173738210.17650/1818-8346-2022-17-3-73-82453Hodgkin lymphoma in patient with primary immunodeficiency: clinical features and treatment approachesK. I. Utesheva0E. S. Belyaeva1T. T. Valiev2A. A. Odzharova3N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaN.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaN.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaPrimary immunodeficiencies (PID) are genetically determined irreversible disorders of structure and/or functions of the immune system's cellular and humoral components, accompanied by frequent infectious diseases and contributing to the development of malignant neoplasms. Lymphomas are the most frequent oncological disease in PID patients: non-Hodgkin's lymphomas occur in 60 % of malignant neoplasms cases, Hodgkin lymphoma - in 20 %, leukemias - in 10 %, solid tumors - in 10 %. The risk of malignant lymphoproliferative diseases in PID patients amounts to 4-25 %, with the overall incidence of cancer 100-200 times higher than in immunocompetent population. Results of malignant neoplasms treatment in children with PID remain unsatisfactory due to the high rate of relapsed, refractory disease and anticancer therapy complications.This paper presents a clinical case of Hodgkin lymphoma with atypical localization in a female PID patient. peculiarities of this case are eye socket soft tissue involvement, slow response to therapy, and a high rate of infectious complications.https://oncohematology.abvpress.ru/ongm/article/view/560primary immunodeficiencynijmegen breakage syndromehodgkin lymphomachemotherapycomplication |
| spellingShingle | K. I. Utesheva E. S. Belyaeva T. T. Valiev A. A. Odzharova Hodgkin lymphoma in patient with primary immunodeficiency: clinical features and treatment approaches Онкогематология primary immunodeficiency nijmegen breakage syndrome hodgkin lymphoma chemotherapy complication |
| title | Hodgkin lymphoma in patient with primary immunodeficiency: clinical features and treatment approaches |
| title_full | Hodgkin lymphoma in patient with primary immunodeficiency: clinical features and treatment approaches |
| title_fullStr | Hodgkin lymphoma in patient with primary immunodeficiency: clinical features and treatment approaches |
| title_full_unstemmed | Hodgkin lymphoma in patient with primary immunodeficiency: clinical features and treatment approaches |
| title_short | Hodgkin lymphoma in patient with primary immunodeficiency: clinical features and treatment approaches |
| title_sort | hodgkin lymphoma in patient with primary immunodeficiency clinical features and treatment approaches |
| topic | primary immunodeficiency nijmegen breakage syndrome hodgkin lymphoma chemotherapy complication |
| url | https://oncohematology.abvpress.ru/ongm/article/view/560 |
| work_keys_str_mv | AT kiutesheva hodgkinlymphomainpatientwithprimaryimmunodeficiencyclinicalfeaturesandtreatmentapproaches AT esbelyaeva hodgkinlymphomainpatientwithprimaryimmunodeficiencyclinicalfeaturesandtreatmentapproaches AT ttvaliev hodgkinlymphomainpatientwithprimaryimmunodeficiencyclinicalfeaturesandtreatmentapproaches AT aaodzharova hodgkinlymphomainpatientwithprimaryimmunodeficiencyclinicalfeaturesandtreatmentapproaches |